Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values

Author:

Cserni Gábor,Vörös András,Liepniece-Karele Inta,Bianchi Simonetta,Vezzosi Vania,Grabau Dorthe,Sapino Anna,Castellano Isabella,Regitnig Peter,Foschini Maria Pia,Zolota Vassiliki,Varga Zsuzsanna,Figueiredo Paulo,Decker Thomas,Focke Cornelia,Kulka Janina,Kaya Handan,Reiner-Concin Angelika,Amendoeira Isabel,Callagy Grace,Caffrey Emer,Wesseling Jelle,Wells Clive

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference16 articles.

1. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67;Gerdes;Am J Pathol,1991

2. Ki67 in breast cancer: prognostic and predictive potential;Yerushalmi;Lancet Oncol,2010

3. MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups;Aleskandarany;Breast Cancer Res Treat,2011

4. Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer;Jones;Breast Cancer Res Treat,2010

5. Assessment of Ki67 in breast cancer: recommendations from the international Ki67 in breast Cancer working group;Dowsett;J Natl Cancer Inst,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3